Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Newborn Screening for SMA and SCID market was valued at US$ 133 million in 2022 and is projected to reach US$ 276.3 million by 2029, at a CAGR of 11.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID. This report contains market size and forecasts of Newborn Screening for SMA and SCID in global, including the following market information:
Global Newborn Screening for SMA and SCID Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Newborn Screening for SMA and SCID companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Newborn Screening for SMA and SCID Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Newborn Screening for SMA and SCID Market Segment Percentages, by Type, 2022 (%)
Instruments
Kits
Software
Global Newborn Screening for SMA and SCID Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Newborn Screening for SMA and SCID Market Segment Percentages, by Application, 2022 (%)
SCID Screening
SMA Screening
Global Newborn Screening for SMA and SCID Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Newborn Screening for SMA and SCID Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Newborn Screening for SMA and SCID revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Newborn Screening for SMA and SCID revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Newborn Screening for SMA and SCID, market overview.
Chapter 2: Global Newborn Screening for SMA and SCID market size in revenue.
Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Newborn Screening for SMA and SCID in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Newborn Screening for SMA and SCID Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Newborn Screening for SMA and SCID Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Newborn Screening for SMA and SCID Overall Market Size
2.1 Global Newborn Screening for SMA and SCID Market Size: 2022 VS 2029
2.2 Global Newborn Screening for SMA and SCID Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Newborn Screening for SMA and SCID Players in Global Market
3.2 Top Global Newborn Screening for SMA and SCID Companies Ranked by Revenue
3.3 Global Newborn Screening for SMA and SCID Revenue by Companies
3.4 Top 3 and Top 5 Newborn Screening for SMA and SCID Companies in Global Market, by Revenue in 2022
3.5 Global Companies Newborn Screening for SMA and SCID Product Type
3.6 Tier 1, Tier 2 and Tier 3 Newborn Screening for SMA and SCID Players in Global Market
3.6.1 List of Global Tier 1 Newborn Screening for SMA and SCID Companies
3.6.2 List of Global Tier 2 and Tier 3 Newborn Screening for SMA and SCID Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Newborn Screening for SMA and SCID Market Size Markets, 2022 & 2029
4.1.2 Instruments
4.1.3 Kits
4.1.4 Software
4.2 By Type - Global Newborn Screening for SMA and SCID Revenue & Forecasts
4.2.1 By Type - Global Newborn Screening for SMA and SCID Revenue, 2018-2023
4.2.2 By Type - Global Newborn Screening for SMA and SCID Revenue, 2024-2029
4.2.3 By Type - Global Newborn Screening for SMA and SCID Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Newborn Screening for SMA and SCID Market Size, 2022 & 2029
5.1.2 SCID Screening
5.1.3 SMA Screening
5.2 By Application - Global Newborn Screening for SMA and SCID Revenue & Forecasts
5.2.1 By Application - Global Newborn Screening for SMA and SCID Revenue, 2018-2023
5.2.2 By Application - Global Newborn Screening for SMA and SCID Revenue, 2024-2029
5.2.3 By Application - Global Newborn Screening for SMA and SCID Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Newborn Screening for SMA and SCID Market Size, 2022 & 2029
6.2 By Region - Global Newborn Screening for SMA and SCID Revenue & Forecasts
6.2.1 By Region - Global Newborn Screening for SMA and SCID Revenue, 2018-2023
6.2.2 By Region - Global Newborn Screening for SMA and SCID Revenue, 2024-2029
6.2.3 By Region - Global Newborn Screening for SMA and SCID Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Newborn Screening for SMA and SCID Revenue, 2018-2029
6.3.2 US Newborn Screening for SMA and SCID Market Size, 2018-2029
6.3.3 Canada Newborn Screening for SMA and SCID Market Size, 2018-2029
6.3.4 Mexico Newborn Screening for SMA and SCID Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Newborn Screening for SMA and SCID Revenue, 2018-2029
6.4.2 Germany Newborn Screening for SMA and SCID Market Size, 2018-2029
6.4.3 France Newborn Screening for SMA and SCID Market Size, 2018-2029
6.4.4 U.K. Newborn Screening for SMA and SCID Market Size, 2018-2029
6.4.5 Italy Newborn Screening for SMA and SCID Market Size, 2018-2029
6.4.6 Russia Newborn Screening for SMA and SCID Market Size, 2018-2029
6.4.7 Nordic Countries Newborn Screening for SMA and SCID Market Size, 2018-2029
6.4.8 Benelux Newborn Screening for SMA and SCID Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Newborn Screening for SMA and SCID Revenue, 2018-2029
6.5.2 China Newborn Screening for SMA and SCID Market Size, 2018-2029
6.5.3 Japan Newborn Screening for SMA and SCID Market Size, 2018-2029
6.5.4 South Korea Newborn Screening for SMA and SCID Market Size, 2018-2029
6.5.5 Southeast Asia Newborn Screening for SMA and SCID Market Size, 2018-2029
6.5.6 India Newborn Screening for SMA and SCID Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Newborn Screening for SMA and SCID Revenue, 2018-2029
6.6.2 Brazil Newborn Screening for SMA and SCID Market Size, 2018-2029
6.6.3 Argentina Newborn Screening for SMA and SCID Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Newborn Screening for SMA and SCID Revenue, 2018-2029
6.7.2 Turkey Newborn Screening for SMA and SCID Market Size, 2018-2029
6.7.3 Israel Newborn Screening for SMA and SCID Market Size, 2018-2029
6.7.4 Saudi Arabia Newborn Screening for SMA and SCID Market Size, 2018-2029
6.7.5 UAE Newborn Screening for SMA and SCID Market Size, 2018-2029
7 Newborn Screening for SMA and SCID Companies Profiles
7.1 Perkinelmer
7.1.1 Perkinelmer Company Summary
7.1.2 Perkinelmer Business Overview
7.1.3 Perkinelmer Newborn Screening for SMA and SCID Major Product Offerings
7.1.4 Perkinelmer Newborn Screening for SMA and SCID Revenue in Global Market (2018-2023)
7.1.5 Perkinelmer Key News & Latest Developments
7.2 Thermo Fisher
7.2.1 Thermo Fisher Company Summary
7.2.2 Thermo Fisher Business Overview
7.2.3 Thermo Fisher Newborn Screening for SMA and SCID Major Product Offerings
7.2.4 Thermo Fisher Newborn Screening for SMA and SCID Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Key News & Latest Developments
7.3 ImmunoIVD
7.3.1 ImmunoIVD Company Summary
7.3.2 ImmunoIVD Business Overview
7.3.3 ImmunoIVD Newborn Screening for SMA and SCID Major Product Offerings
7.3.4 ImmunoIVD Newborn Screening for SMA and SCID Revenue in Global Market (2018-2023)
7.3.5 ImmunoIVD Key News & Latest Developments
7.4 Labsystems Diagnostics
7.4.1 Labsystems Diagnostics Company Summary
7.4.2 Labsystems Diagnostics Business Overview
7.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Major Product Offerings
7.4.4 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue in Global Market (2018-2023)
7.4.5 Labsystems Diagnostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
